• Sectors we work in banner(2)

    Quick Reads

The ongoing fight against fakes

When counterfeit goods are mentioned, initial thoughts may be of luxury items such as handbags copied in a far cheaper and more accessible form. Hidden behind such goods is the harm done to rights holders, who have invested time and money developing and producing a product, and the organised crime and downstream harm caused by such counterfeit items. However, other products are also counterfeited and the impact to the consumer can be more immediate and dangerous – electrical goods and pharmaceuticals are two categories that are also frequently copied.

EUROPOL recently coordinated the fourth edition of Operation SHIELD, a global effort to tackle fake pharmaceuticals.  The operation saw 1,284 individuals charged and took fake medicines worth EUR 64 million off EU markets.

The sale of fake pharmaceuticals, and illegal trafficking of pharmaceuticals, continues to be a growing issue and is a significant public health problem.

The Internet remains an enticing outlet for suppliers of counterfeit goods and social media is a current popular forum for selling counterfeit and illegally sold medicines. Of key importance is educating users of social media, particularly younger generations, on the significant safety risks associated with sourcing pharmaceuticals outside the legitimate supply chain. As consumers, it is key that we question what the item is and where it has come from.

Brand owners should seek to protect and enforce their trade mark rights to help curb the proliferation of counterfeit products worldwide and protect consumers. 

The EUROPOL press release makes for impressive reading but the fight against counterfeiters is ongoing. Vigilance by consumers and brand owners, and protection of important intellectual property, are key.


Medicines are often counterfeited in underground laboratories without any regulation or safety measures in place. Counterfeit products created under such circumstances do not produce the desired effect; in the best case scenario the patient remains untreated, however such products can cause serious health issues or be potentially lethal.

Our thinking

  • IBA Annual Conference 2024

    Charlotte Ford


  • Re UKCloud: The importance of exercising control over a fixed charge asset

    Cara Whiffin


  • Bloomberg quotes Dominic Lawrance on pledges to scrap preferential tax treatment for non-doms

    Dominic Lawrance

    In the Press

  • Consumer Duty Board Report

    Richard Ellis


  • Standard of repair put to the test - Estates Gazette Q&A

    Emma Humphreys


  • A Closer Look at the Current State of Artificial Intelligence Regulation in the Gulf

    Mark Hill

    Quick Reads

  • Is the horizon level? Current updates and predictions for Competition Law in the UAE

    William Reichert


  • Injunctions against potential protesters - Estates Gazette Q&A

    Samuel Lear


  • Michael Powner, Isobel Goodman and Hauwa Ottun write for Law 360 on the Tips Act

    Michael Powner

    In the Press

  • Emily Chalkley writes for The Times on how best to use employee influencers

    Emily Chalkley

    In the Press

  • LIDW: Liability imposed on UK Directors and how to mitigate the risks

    Claudine Morgan


  • The Lawyer covers our Training Contract support, in light of the shift to the SQE

    Karen Stages

    In the Press

  • The Use of Experts in International Arbitration

    Peter Smith


  • The Digital Markets, Competition and Consumers Act receives Royal Assent! What can we expect to see in consumer law changes?

    Dillon Ravikumar


  • Volunteers’ Week 2024: Celebrating Our People


  • The Telegraph quotes Sarah Jane Boon on potential issues around Labour’s pledge to levy VAT on private school fees

    Sarah Jane Boon

    In the Press

  • Property Patter: Great Estates Miniseries - part 2

    Cara Imbrailo


  • Property Week quotes Claire Fallows on Labour's proposed new towns programme

    Claire Fallows

    In the Press

  • Business Green quotes Caroline Greenwell on the FCA's new sustainability disclosure regime

    Caroline Greenwell

    In the Press

  • Spear's quotes Sarah Jane Boon on issues around VAT on private school fees

    Sarah Jane Boon

    In the Press

Back to top